Clinical Trial Update: Platelet Inhibition to Target Reperfusion Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating platelet inhibition to target reperfusion injury in STEMI patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Snippet

Sponsor: National Heart Centre Singapore | Conditions: STEMI | Phase 2 | Status: UNKNOWN